Search Results
Jun 22, 2025, 15:35 ET Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress
al. Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries. Ann Intern Med. 2019;171:540-546.Kim JY, You CW. The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia
More news about: Novo Nordisk
Jun 22, 2025, 09:00 ET CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM
Garvey T, Blüher M, Contreras C, et al. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2025;10.1056/NEJMoa2502081.ClinicalTrials.gov. A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight
More news about: NOVO NORDISK INC.
Jun 20, 2025, 05:13 ET 全新SKINVIVE® 昇光針® 矚目登場 -- 引領突破水光界限
elasticity, mouldability, tissue integration, spreadability. May 2020. 7. Purnamawati S et al. Clin Med Res. 2017;15(3-4);75–87 8. Akinbiyi T et al. Plast Reconstr Surg Glob Open. 2020;8(10):e2763.
More news about: Allergan Aesthetics
Jun 19, 2025, 17:31 ET Delta-like Ligand 3 Targeted Therapies Market is Predicted to Heat Up During the Forecast Period (2025-2034) Across 7MM Owing to a Robust Pipeline | DelveInsight
Merck, Daiichi Sankyo, Legend Biotech, Novartis, Abdera Therapeutics, Boehringer Ingelheim, Chugai Pharmaceutical, Roche, Molecular Partners, Orano Med, Zai Lab, Allogene Therapeutics, and others, are developing novel delta-like ligand 3 targeted therapies that can
More news about: DelveInsight Business Research, LLP
Jun 19, 2025, 08:00 ET Johnson & Johnson Launches VOLT™ Wrist and Proximal Humerus Plating Systems in the U.S.
#501988740.2 Taskesen A, Göçer A, Uzel K, Yaradılmış YU. Effect of osteoporosis on proximal humerus fractures. Orthop J Sports Med. 2020;8(12):2325967120985399. doi:10.1177/2151459320985399.3 Nellans KW, Kowalski E, Chung KC. The epidemiology of distal radius
More news about: Johnson & Johnson MedTech
Jun 18, 2025, 07:30 ET Remepy's Mobile App Shown to Rewire Brain, Modulate Immune System and Improve Mood in Adults with Subjective Cognitive Decline
al. Mobile application leads to psychological improvement and correlated neuroimmune function change in subjective cognitive decline. npj Digit. Med. 8, 359 (2025). https://doi.org/10.1038/s41746-025-01765-1
More news about: Remepy
Jun 17, 2025, 09:20 ET Lung Cancer Research Foundation Announces New Research Collaboration with Boehringer Ingelheim
harbouring HER2 alterations. ESMO Open 6:100260, 2021Li BT et al. Trastuzumab deruxtecan in HER2-mutant non-small-cell lung cancer, N Engl J Med 386:241, 2022. About the Lung Cancer Research Foundation (LCRF)The Lung Cancer Research Foundation®
More news about: Lung Cancer Research Foundation
Jun 17, 2025, 08:25 ET San Raffaele Hospital: World's First Case Study Demonstrates the Effectiveness of Spinal Cord Neurostimulation in a Paraplegic Patient with Severe Conus Medullaris Injury
The study, published in Med by Cell Press and authored by physicians and researchers from the MINE Lab, documents the recovery of walking ability through epidural electrical stimulation in a paraplegic patient with a spinal cord injury at the T11–T12 level. These types of injuries account for
More news about: IRCCS Ospedale San Raffaele; UniSR